Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-02-28 Sale |
2025-02-28 5:19 pm |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
1,938 | $34 | $65,892 | 15,957 (Direct) |
View |
2025-02-25 Sale |
2025-02-25 6:38 pm |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
3,743 | $35.26 | $131,978 | 12,284 (Direct) |
View |
2025-02-20 Sale |
2025-02-20 5:18 pm |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
1,327 | $35.69 | $47,361 | 34,003 (Direct) |
View |
2025-02-12 Sale |
2025-02-14 5:12 pm |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
349,340 | $33.92 | $11,848,975 | 179,151 (Direct) |
View |
2025-01-30 Sale |
2025-01-31 8:42 pm |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
100,918 | $32.05 | $3,234,382 | 492,619 (Direct) |
View |
2024-12-09 Sale |
2024-12-09 8:53 pm |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
61,151 | $32.07 | $1,961,406 | 593,537 (Direct) |
View |
2024-12-09 Sale |
2024-12-09 8:51 pm |
Alkermes plc. | ALKS | LAURENCIN CATO T Director |
2,691 | $31.85 | $85,708 | 39,155 (Direct) |
View |
2024-12-05 Sale |
2024-12-05 6:01 pm |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
9,221 | $31.5 | $290,462 | 59,730 (Direct) |
View |
2024-12-04 Sale |
2024-12-04 4:52 pm |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
14,349 | $30.77 | $441,550 | 68,951 (Direct) |
View |
2024-11-27 Sale |
2024-11-27 4:22 pm |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
5,208 | $29.15 | $151,813 | 60,703 (Direct) |
View |
2024-11-11 Sale |
2024-11-12 4:48 pm |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
58,996 | $30.08 | $1,774,576 | 212,474 (Direct) |
View |
2024-11-06 Sale |
2024-11-06 7:47 pm |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
10,471 | $29.53 | $309,169 | 99,238 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-11 Exercise |
2025-04-14 5:17 pm |
N/A N/A |
Alkermes plc. | ALKS | Lurker Nancy Director |
6,075 | $0 | 12,119 (Direct) |
View |
2025-04-11 Tax Withholding |
2025-04-14 5:17 pm |
N/A N/A |
Alkermes plc. | ALKS | Lurker Nancy Director |
1,459 | $27 | 12,119 (Direct) |
View |
2025-02-26 Exercise |
2025-02-28 5:19 pm |
N/A N/A |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
2,746 | $0 | 15,957 (Direct) |
View |
2025-02-26 Tax Withholding |
2025-02-28 5:19 pm |
N/A N/A |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
808 | $34.8 | 15,957 (Direct) |
View |
2025-02-26 Exercise |
2025-02-28 5:18 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
5,409 | $0 | 109,104 (Direct) |
View |
2025-02-26 Tax Withholding |
2025-02-28 5:18 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
2,402 | $34.8 | 109,104 (Direct) |
View |
2025-02-26 Exercise |
2025-02-28 5:17 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
8,322 | $0 | 226,335 (Direct) |
View |
2025-02-26 Tax Withholding |
2025-02-28 5:17 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
3,695 | $34.8 | 226,335 (Direct) |
View |
2025-02-26 Exercise |
2025-02-28 5:16 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
6,866 | $0 | 98,338 (Direct) |
View |
2025-02-26 Tax Withholding |
2025-02-28 5:16 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
3,049 | $34.8 | 98,338 (Direct) |
View |
2025-02-26 Exercise |
2025-02-28 5:15 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
6,866 | $0 | 224,853 (Direct) |
View |
2025-02-26 Tax Withholding |
2025-02-28 5:15 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
3,049 | $34.8 | 224,853 (Direct) |
View |
2025-02-26 Exercise |
2025-02-28 5:14 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
5,617 | $0 | 165,050 (Direct) |
View |
2025-02-26 Tax Withholding |
2025-02-28 5:14 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
2,494 | $34.8 | 165,050 (Direct) |
View |
2025-02-22 Tax Withholding |
2025-02-25 6:39 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
6,714 | $35.32 | 215,817 (Direct) |
View |
2025-02-22 Exercise |
2025-02-25 6:39 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
15,121 | $0 | 215,817 (Direct) |
View |
2025-02-22 Tax Withholding |
2025-02-25 6:39 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
8,185 | $35.32 | 214,217 (Direct) |
View |
2025-02-22 Exercise |
2025-02-25 6:39 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
18,432 | $0 | 214,217 (Direct) |
View |
2025-02-22 Tax Withholding |
2025-02-25 6:38 pm |
N/A N/A |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
1,655 | $35.32 | 12,284 (Direct) |
View |
2025-02-22 Exercise |
2025-02-25 6:38 pm |
N/A N/A |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
5,398 | $0 | 12,284 (Direct) |
View |
2025-02-22 Tax Withholding |
2025-02-25 6:37 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
5,741 | $35.32 | 156,723 (Direct) |
View |
2025-02-22 Exercise |
2025-02-25 6:37 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
12,934 | $0 | 156,723 (Direct) |
View |
2025-02-22 Tax Withholding |
2025-02-25 6:36 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
6,003 | $35.32 | 102,683 (Direct) |
View |
2025-02-22 Exercise |
2025-02-25 6:36 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
13,517 | $0 | 102,683 (Direct) |
View |
2025-02-22 Tax Withholding |
2025-02-25 6:35 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
8,866 | $35.32 | 89,302 (Direct) |
View |
2025-02-22 Exercise |
2025-02-25 6:35 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
19,968 | $0 | 89,302 (Direct) |
View |
2025-02-18 Exercise |
2025-02-20 5:18 pm |
N/A N/A |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
2,033 | $0 | 34,003 (Direct) |
View |
2025-02-18 Tax Withholding |
2025-02-20 5:18 pm |
N/A N/A |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
706 | $35.9 | 34,003 (Direct) |
View |
2025-02-19 Option Award |
2025-02-20 5:18 pm |
N/A 2035-02-19 |
Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) |
24,252 | $0 | 34,003 (Direct) |
View |
2025-02-18 Exercise |
2025-02-20 5:17 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
6,354 | $0 | 163,308 (Direct) |
View |
2025-02-18 Tax Withholding |
2025-02-20 5:17 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
1,869 | $35.9 | 163,308 (Direct) |
View |
2025-02-19 Option Award |
2025-02-20 5:17 pm |
N/A 2035-02-19 |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
74,599 | $0 | 163,308 (Direct) |
View |
2025-02-18 Exercise |
2025-02-20 5:16 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
6,354 | $0 | 293,069 (Direct) |
View |
2025-02-18 Tax Withholding |
2025-02-20 5:16 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
2,822 | $35.9 | 293,069 (Direct) |
View |
2025-02-19 Option Award |
2025-02-20 5:16 pm |
N/A 2035-02-19 |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
94,683 | $0 | 293,069 (Direct) |
View |
2025-02-18 Exercise |
2025-02-20 5:15 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
6,354 | $0 | 144,235 (Direct) |
View |
2025-02-18 Tax Withholding |
2025-02-20 5:15 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
1,869 | $35.9 | 144,235 (Direct) |
View |
2025-02-18 Exercise |
2025-02-20 5:14 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
8,896 | $0 | 310,159 (Direct) |
View |
2025-02-18 Tax Withholding |
2025-02-20 5:14 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
3,950 | $35.9 | 310,159 (Direct) |
View |
2025-02-19 Option Award |
2025-02-20 5:14 pm |
N/A 2035-02-19 |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
114,768 | $0 | 310,159 (Direct) |
View |
2025-02-18 Exercise |
2025-02-20 5:13 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
8,896 | $0 | 166,401 (Direct) |
View |
2025-02-18 Tax Withholding |
2025-02-20 5:13 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
3,950 | $35.9 | 166,401 (Direct) |
View |
2025-02-19 Option Award |
2025-02-20 5:13 pm |
N/A 2035-02-19 |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
94,683 | $0 | 166,401 (Direct) |
View |
2025-02-19 Option Award |
2025-02-20 5:11 pm |
N/A 2035-02-19 |
Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc |
293,921 | $0 | 293,921 (Direct) |
View |
2025-02-12 Exercise |
2025-02-14 5:12 pm |
N/A 2030-02-20 |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
343,615 | $0 | 179,151 (Direct) |
View |
2025-02-12 Exercise |
2025-02-14 5:12 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
111,630 | $19.34 | 179,151 (Direct) |
View |
2025-02-13 Exercise |
2025-02-14 5:12 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
108,833 | $31.93 | 179,151 (Direct) |
View |
2025-02-13 Exercise |
2025-02-14 5:12 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
35,586 | $24.59 | 179,151 (Direct) |
View |
2025-02-12 Exercise |
2025-02-14 5:12 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
87,566 | $20.03 | 179,151 (Direct) |
View |
2025-02-06 Tax Withholding |
2025-02-07 8:36 pm |
N/A N/A |
Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc |
79,925 | $31.39 | 1,290,390 (Direct) |
View |
2025-02-06 Option Award |
2025-02-07 8:36 pm |
N/A N/A |
Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc |
190,640 | $0 | 1,290,390 (Direct) |
View |
2025-02-06 Tax Withholding |
2025-02-07 8:35 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
7,399 | $31.39 | 77,869 (Direct) |
View |
2025-02-06 Option Award |
2025-02-07 8:35 pm |
N/A N/A |
Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer |
24,565 | $0 | 77,869 (Direct) |
View |
2025-02-06 Tax Withholding |
2025-02-07 8:33 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
10,647 | $31.39 | 181,548 (Direct) |
View |
2025-02-06 Option Award |
2025-02-07 8:33 pm |
N/A N/A |
Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer |
34,393 | $0 | 181,548 (Direct) |
View |
2025-02-06 Tax Withholding |
2025-02-07 8:31 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
15,083 | $31.39 | 63,600 (Direct) |
View |
2025-02-06 Option Award |
2025-02-07 8:31 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
34,393 | $0 | 63,600 (Direct) |
View |
2025-02-06 Tax Withholding |
2025-02-07 8:30 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
9,752 | $31.39 | 188,499 (Direct) |
View |
2025-02-06 Option Award |
2025-02-07 8:30 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
32,350 | $0 | 188,499 (Direct) |
View |
2025-02-06 Tax Withholding |
2025-02-07 8:29 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
7,514 | $31.39 | 133,395 (Direct) |
View |
2025-02-06 Option Award |
2025-02-07 8:29 pm |
N/A N/A |
Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer |
24,565 | $0 | 133,395 (Direct) |
View |
2025-01-30 Exercise |
2025-01-31 8:42 pm |
N/A 2030-02-20 |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
97,632 | $0 | 492,619 (Direct) |
View |
2025-01-30 Exercise |
2025-01-31 8:42 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
26,589 | $19.34 | 492,619 (Direct) |
View |
2025-01-30 Exercise |
2025-01-31 8:42 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
18,345 | $26.82 | 492,619 (Direct) |
View |
2025-01-30 Exercise |
2025-01-31 8:42 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
23,542 | $24.59 | 492,619 (Direct) |
View |
2025-01-30 Exercise |
2025-01-31 8:42 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
29,156 | $20.03 | 492,619 (Direct) |
View |
2024-12-09 Exercise |
2024-12-09 8:53 pm |
N/A 2030-02-20 |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
48,997 | $0 | 593,537 (Direct) |
View |
2024-12-09 Exercise |
2024-12-09 8:53 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
12,090 | $19.34 | 593,537 (Direct) |
View |
2024-12-09 Exercise |
2024-12-09 8:53 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
12,411 | $26.82 | 593,537 (Direct) |
View |
2024-12-09 Exercise |
2024-12-09 8:53 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
12,044 | $24.59 | 593,537 (Direct) |
View |
2024-12-09 Exercise |
2024-12-09 8:53 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
12,452 | $20.03 | 593,537 (Direct) |
View |
2024-12-08 Exercise |
2024-12-09 8:51 pm |
N/A N/A |
Alkermes plc. | ALKS | LAURENCIN CATO T Director |
6,854 | $0 | 39,155 (Direct) |
View |
2024-12-09 Exercise |
2024-12-09 8:51 pm |
N/A N/A |
Alkermes plc. | ALKS | LAURENCIN CATO T Director |
2,691 | $22.52 | 39,155 (Direct) |
View |
2024-12-08 Tax Withholding |
2024-12-09 8:51 pm |
N/A N/A |
Alkermes plc. | ALKS | LAURENCIN CATO T Director |
958 | $31.46 | 39,155 (Direct) |
View |
2024-11-11 Exercise |
2024-11-12 4:48 pm |
N/A 2030-02-20 |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
43,058 | $0 | 212,474 (Direct) |
View |
2024-11-11 Exercise |
2024-11-12 4:48 pm |
N/A N/A |
Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer |
43,058 | $20.03 | 212,474 (Direct) |
View |
2024-08-03 Exercise |
2024-08-05 4:13 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
2,014 | $0 | 169,930 (Direct) |
View |
2024-08-03 Tax Withholding |
2024-08-05 4:13 pm |
N/A N/A |
Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. |
895 | $27.72 | 169,930 (Direct) |
View |
2024-06-29 Exercise |
2024-07-01 5:04 pm |
N/A N/A |
Alkermes plc. | ALKS | Wright Christopher I Director |
6,104 | $0 | 14,416 (Direct) |
View |
2024-06-29 Tax Withholding |
2024-07-01 5:04 pm |
N/A N/A |
Alkermes plc. | ALKS | Wright Christopher I Director |
1,465 | $24.1 | 14,416 (Direct) |
View |
2024-06-29 Exercise |
2024-07-01 5:02 pm |
N/A N/A |
Alkermes plc. | ALKS | Wilson Frank Anders Director |
6,104 | $0 | 24,995 (Direct) |
View |
2024-06-29 Tax Withholding |
2024-07-01 5:02 pm |
N/A N/A |
Alkermes plc. | ALKS | Wilson Frank Anders Director |
1,465 | $24.1 | 24,995 (Direct) |
View |
2024-06-29 Exercise |
2024-07-01 5:01 pm |
N/A N/A |
Alkermes plc. | ALKS | snyderman nancy lynn MD Director |
6,104 | $0 | 25,422 (Direct) |
View |
2024-06-29 Tax Withholding |
2024-07-01 5:01 pm |
N/A N/A |
Alkermes plc. | ALKS | snyderman nancy lynn MD Director |
1,465 | $24.1 | 25,422 (Direct) |
View |
2024-06-29 Exercise |
2024-07-01 4:59 pm |
N/A N/A |
Alkermes plc. | ALKS | MCKEON BRIAN P Director |
6,104 | $0 | 37,780 (Direct) |
View |
2024-06-29 Tax Withholding |
2024-07-01 4:59 pm |
N/A N/A |
Alkermes plc. | ALKS | MCKEON BRIAN P Director |
1,465 | $24.1 | 37,780 (Direct) |
View |